Alcohol use disorders among Nigerian University students: Prevalence and Sociodemographic correlates

Adewuya, Abiodun O.; Ola, B.; Aloba, Olutayo; Mapayi, Boladale; Ibıgbamı, Olanrewaju; Adewumi, Tomilola

doi:10.4314/njpsyc.v5i1.39893

Cited by 16 publications

(23 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…[2][3][4][5][6] If anything, worldwide use of alcohol is increasing, particularly in developing countries, and age at first drink is decreasing, suggesting that there will be an even greater need for effective treatments for alcohol dependence in the future. [7][8][9] Although most individuals with alcohol dependence who seek treatment receive either psychosocial counseling or participate in self-help groups without the use of pharmacological interventions, 10 current practice guidelines recommend pharmacotherapy with behavioral treatments. 11 In the United States, Food and Drug Administration approved medications for alcohol dependence in-clude disulfiram (Antabuse R ) (introduced in 1948), oral naltrexone (ReVia R , Depade R ) (approved in 1994), acamprosate Calcium (Campral R ) (approved in 2004), and extended-release injectable naltrexone (XR-NTX; Vivitrol R ) (approved in 2006).…”

Section: Medications For Alcohol Dependencementioning

confidence: 99%

Intramuscular extended‐release naltrexone: current evidence

Gastfriend

2011

Annals of the New York Academy of Sciences

View full text Add to dashboard Cite

Extended-release naltrexone (XR-NTX; Vivitrol), developed to address poor adherence in addictive disorders, is approved for use in alcohol and opioid-dependence disorders. In alcohol-dependent adults with ≥ 4-day initial abstinence, XR-NTX increased initial and 6-month abstinence. An fMRI study found that XR-NTX attenuated the salience of alcohol visual and olfactory cues in the absence of alcohol, and post hoc analyses demonstrated efficacy even during high cue-exposure holiday periods. Safety and tolerability have generally been good, without adverse hepatic impact or intractable acute pain management. XR-NTX use appears feasible in primary care and public systems, and retrospective claims analyses have found cost savings and decreased intensive service utilization relative to oral agents. In opioid dependence, following detoxification, XR-NTX shows efficacy for maintaining abstinence, improving retention, decreasing craving, and preventing relapse. Trials are also exploring its use for the treatment of stimulant dependence. XR-NTX appears compatible with counseling and self-help attendance. While more research is needed, current findings suggest that a formulation of naltrexone that was sought beginning over three decades ago is fulfilling its promise as an extended-release pharmacotherapeutic.

show abstract

Section: Medications For Alcohol Dependencementioning

confidence: 99%

Intramuscular extended‐release naltrexone: current evidence

Gastfriend

2011

Annals of the New York Academy of Sciences

View full text Add to dashboard Cite

show abstract

“…Other risk factors for stroke like alcohol use and cigarette smoking are very common in many Nigerian communities [33] [34]. These substances were not significant risk for stroke in the index study probably because we surveyed the rates of current use rate than lifetime use of these substances.…”

Section: Discussionmentioning

confidence: 97%

The Prevalence of Stroke Survivors in Urban Slums in Enugu, Nigeria

Ekenze¹,

Adikaibe²,

Obinna³

et al. 2019

OJPM

View full text Add to dashboard Cite

Background: Stroke is one of the commonest non-communicable diseases and the commonest cause of death in adult neurology wards. Stroke prevalence in sub Saharan Africa has dramatically increased over the past decades possibly due to changing life styles, poverty, poor health infrastructures which had led to increased risk factors for stroke. Poor nutrition and lack of access to standard medical care, predispose to high rates of stroke morbidity and mortality hence possible low prevalence. Little is known about the prevalence of stroke in people with low socio-economic status in Nigeria. Objectives: The main objective of this study was to determine the prevalence of stroke in two urban slums in south east Nigeria. Materials and Methods: This was a cross sectional descriptive study carried out in two slums in Enugu, South East Nigeria. Participants were screened using a stroke specific questionnaire and further examined by two independent neurologists for evidence of focal neurological deficits. Analysis was done by SPSS version 22. Results: A total of 1440 participants were surveyed in the study; 769 (53.4) females and 671 (46.6%) males. About 22.3% (321) screened positive for various neurological diseases out of which 17 (5.3%) had evidence for stroke giving an overall prevalence of 1.2% (males 9 (1.3%) vs females 8 (1%) p = 0.6). The mean age of stroke survivors was 60.1 years, similar in males and females (p = 0.6). The odds ratio for stroke from 40 years showed progress increment doubling between 60 and 70 years and tripled between 40 and 70 years. Age, lower level of education, positive history of hypertension, sickle How to cite this paper: Ekenze, O.

show abstract

“…This is similar to 4.3% reported among University students in Nigeria. 22 Comparing this with the Moderate risk of 8.9% and high risk of 2.8% respectively on ASSIST, there is a significant difference. A previous similar study used only ASSIST without diagnosing AUDs.…”

Section: Discussionmentioning

confidence: 99%

Alcohol Use Disorders among Participants of a Community Outreach in Jos, Nigeria: Prevalence, Correlates and ease of acceptance of Brief Intervention

Okonoda¹

2017

jmscr

View full text Add to dashboard Cite

Alcohol use disorders among Nigerian University students: Prevalence and Sociodemographic correlates

Cited by 16 publications

References 9 publications

Intramuscular extended‐release naltrexone: current evidence

Intramuscular extended‐release naltrexone: current evidence

The Prevalence of Stroke Survivors in Urban Slums in Enugu, Nigeria

Alcohol Use Disorders among Participants of a Community Outreach in Jos, Nigeria: Prevalence, Correlates and ease of acceptance of Brief Intervention

Contact Info

Product

Resources

About